Enjoy complimentary customisation on priority with our Enterprise License!
The global west Nile virus therapeutics market has the potential to grow by USD 23.46 million during 2019-2023. The growth momentum will accelerate throughout the forecast period, and the market will grow at a CAGR of over 2%.
The availability of over-the-counter therapeutics is one of the major factors driving market growth. The US, the UK, and Canada are currently the significant markets for West Nile Virus Therapeutics.
The report provides a detailed analysis of the market by application and geography. Also, the report analyzes the market’s competitive landscape and offers information on several market vendors.
Browse TOC and LoE with selected illustrations and example pages from the West Nile Virus therapeutics market report
The West Nile virus therapeutics market is fragmented, and the degree of fragmentation will increase during the forecast period. Aurobindo Pharma Ltd., Bayer AG, GlaxoSmithKline Plc are some of the major market participants. Though the accelerating growth momentum will offer immense growth opportunities, the asymptomatic nature of the disease will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The report provides information on the production, sustainability, and prospects of several companies, including:
Because of the availability of OTC therapeutics for the treatment of the symptoms associated with West Nile Virus infection, West Nile Virus therapeutics are preferred to cure encephalitis and meningitis. The availability of these OTC therapeutics allows patients to self-medicate and treat their illness at home. The low cost of these drugs without the need for prescription increases patient adherence, thereby driving market growth. Considering the easy availability and high demand for these therapeutics, manufacturers are focusing on awareness programs. This will subsequently drive market growth over the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
North America is a significant market for West Nile virus therapeutics. The rising disposable income of people, the availability of high-quality healthcare infrastructure, and improved diagnostic methods are driving market growth in the region.
During the forecast period, about 41% of the overall market growth will originate from North America. Moreover, market growth in this region will be faster than the growth of the market in Asia and ROW.
Request for a FREE sample and Get more information on the market contribution of various application segments
The occurrence of different symptoms attributes to the demand in the neuroinvasive application. They are also highly preferred by clinical products manufacturers and companies that manufacture therapeutics for clinical conditions such as meningitis, encephalitis, and acute flaccid paralysis.
Market growth in the neuroinvasive application segment will be slower than the growth of the market in the non-neuroinvasive application segment.
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY APPLICATION
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.